These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6210722)
1. Efficacy of desipramine in endogenomorphically depressed patients. Stewart JW; Quitkin F; Fyer A; Rifkin A; McGrath P; Liebowitz M; Rosnick L; Klein DF J Affect Disord; 1980 Sep; 2(3):165-76. PubMed ID: 6210722 [TBL] [Abstract][Full Text] [Related]
2. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472 [TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. Leonard HL; Meyer MC; Swedo SE; Richter D; Hamburger SD; Allen AJ; Rapoport JL; Tucker E J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1460-8. PubMed ID: 8543513 [TBL] [Abstract][Full Text] [Related]
4. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder. Sasson Y; Iancu I; Fux M; Taub M; Dannon PN; Zohar J Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287 [TBL] [Abstract][Full Text] [Related]
5. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Zohar J; Insel TR Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259 [TBL] [Abstract][Full Text] [Related]
6. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696 [TBL] [Abstract][Full Text] [Related]
7. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. Fawcett J; Edwards JH; Kravitz HM; Jeffriess H J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312 [TBL] [Abstract][Full Text] [Related]
8. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Katz MM; Tekell JL; Bowden CL; Brannan S; Houston JP; Berman N; Frazer A Neuropsychopharmacology; 2004 Mar; 29(3):566-79. PubMed ID: 14627997 [TBL] [Abstract][Full Text] [Related]
9. Fluency changes in persons who stutter following a double blind trial of clomipramine and desipramine. Stager SV; Ludlow CL; Gordon CT; Cotelingam M; Rapoport JL J Speech Hear Res; 1995 Jun; 38(3):516-25. PubMed ID: 7674643 [TBL] [Abstract][Full Text] [Related]
10. An inverse correlation between serum levels of desmethylimipramine and melatonin-like immunoreactivity in DMI-responsive depressives. Halbreich U; Weinberg U; Stewart J; Klein DF; Weitzman ED; Quitkin FM Psychiatry Res; 1981 Feb; 4(1):109-13. PubMed ID: 6938997 [TBL] [Abstract][Full Text] [Related]
11. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study. Bloch M; Schwartzman Y; Bonne O; Lerer B J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056 [TBL] [Abstract][Full Text] [Related]
12. Paraphilias: a double-blind crossover comparison of clomipramine versus desipramine. Kruesi MJ; Fine S; Valladares L; Phillips RA; Rapoport JL Arch Sex Behav; 1992 Dec; 21(6):587-93. PubMed ID: 1482282 [TBL] [Abstract][Full Text] [Related]
13. Noradrenergic versus serotonergic antidepressants: predictors of treatment response. Schatzberg AF J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626 [TBL] [Abstract][Full Text] [Related]
14. Hormonal responses to zimelidine and desipramine in depressed patients. Calil HM; Lesieur P; Gold PW; Brown GM; Zavadil AP; Potter WZ Psychiatry Res; 1984 Nov; 13(3):231-42. PubMed ID: 6098913 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness. Stewart JW; Quitkin FM; Liebowitz MR; McGrath PJ; Harrison WM; Klein DF Arch Gen Psychiatry; 1983 Feb; 40(2):202-7. PubMed ID: 6337580 [TBL] [Abstract][Full Text] [Related]
16. 2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response? Stern SL; Cooper TB; Nelson LD; Johnson MH; Suckow RF Int Clin Psychopharmacol; 1996 Dec; 11(4):219-27. PubMed ID: 9031987 [TBL] [Abstract][Full Text] [Related]
17. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression. Sabelli HC; Fawcett J; Javaid JI; Bagri S Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437 [TBL] [Abstract][Full Text] [Related]
19. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma. Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794 [TBL] [Abstract][Full Text] [Related]
20. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion. Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]